Outcome of Intravitreal Dexamethasone Implant Use in Uveitic Eyes Undergoing Pars Plana Vitrectomy Surgery

References

• de Smet MD, Taylor SR, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011;30(6):452–470. doi:https://doi.org/10.1016/j.preteyeres.2011.06.005.
   PubMed Web of Science ®Google Scholar
• Henry CR, Becker MD, Yang Y, Davis JL. Pars plana vitrectomy for the treatment of uveitis. Am J Ophthalmol. 2018;190:142–149. doi:https://doi.org/10.1016/j.ajo.2018.03.031.
   PubMed Web of Science ®Google Scholar
• Kiryu J, Kita M, Tanabe T, Yamashiro K, Miyamoto N, Ieki Y. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology. 2001;108(6):1140–1144. doi:https://doi.org/10.1016/S0161-6420(01)00558-9.
   PubMed Web of Science ®Google Scholar
• Wiechens B, Nolle B, Reichelt JA. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol. 2001;239(7):474–481. doi:https://doi.org/10.1007/s004170100254.
   PubMed Web of Science ®Google Scholar
• Quinones K, Choi JY, Yilmaz T, Kafkala C, Letko E, Foster CS. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study. Ocul Immunol Inflamm. 2010;18(5):411–417. doi:https://doi.org/10.3109/09273948.2010.501132.
   PubMed Web of Science ®Google Scholar
• Scott RA, Haynes RJ, Orr GM, Cooling RJ, Pavesio CE, Charteris DG. Vitreous surgery in the management of chronic endogenous posterior uveitis. Eye (Lond). 2003;17(2):221–227. doi:https://doi.org/10.1038/sj.eye.6700299.
   PubMed Web of Science ®Google Scholar
• Callaway NF, Gonzalez MA, Yonekawa Y, et al. Outcomes of pars plana vitrectomy for macular hole in patients with uveitis. Retina. 2018;38(Suppl 1):S41–S48. doi:https://doi.org/10.1097/IAE.0000000000001942.
   PubMedGoogle Scholar
• Adan A, Pelegrin L, Rey A, et al. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Retina. 2013;33(7):1435–1440. doi:https://doi.org/10.1097/IAE.0b013e31827e247b.
   PubMed Web of Science ®Google Scholar
• Nobre-Cardoso J, Champion E, Darugar A, Fel A, Lehoang P, Bodaghi B. Treatment of non-infectious uveitic macular edema with the intravitreal dexamethasone implant. Ocul Immunol Inflamm. 2017;25(4):447–454. doi:https://doi.org/10.3109/09273948.2015.1132738.
   PubMed Web of Science ®Google Scholar
• Pelegrin L, de la Maza MS, Molins B, Rios J, Adan A. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis. Eye (Lond). 2015;29(7):943–950. doi:https://doi.org/10.1038/eye.2015.73.
   PubMed Web of Science ®Google Scholar
• Tomkins-Netzer O, Taylor SR, Bar A, et al. Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis. Ophthalmology. 2014;121(8):1649–1654. doi:https://doi.org/10.1016/j.ophtha.2014.02.003.
   PubMed Web of Science ®Google Scholar
• Boyer DS, Faber D, Gupta S, et al. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina. 2011;31(5):915–923. doi:https://doi.org/10.1097/IAE.0b013e318206d18c.
   PubMed Web of Science ®Google Scholar
• Zheng A, Chin EK, Almeida DR, Tsang SH, Mahajan VB. Combined vitrectomy and intravitreal dexamethasone (Ozurdex) sustained-release implant. Retina. 2016;36(11):2087–2092. doi:https://doi.org/10.1097/IAE.0000000000001063.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92(4):467–471. doi:https://doi.org/10.1016/S0161-6420(85)34001-0.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Sugar EA, Holbrook JT, et al. Periocular triamcinolone vs. Intravitreal triamcinolone vs. Intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial. Ophthalmology. 2019;126(2):283–295. doi:https://doi.org/10.1016/j.ophtha.2018.08.021.
   PubMed Web of Science ®Google Scholar
• Sugar EA, Jabs DA, Altaweel MM, et al. Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography. Am J Ophthalmol. 2011;152(6):1044–1052 e1045. doi:https://doi.org/10.1016/j.ajo.2011.05.028.
   PubMed Web of Science ®Google Scholar
• Mateo C, Alkabes M, Bures-Jelstrup A, et al. Scleral fixation of dexamethasone intravitreal implant (OZURDEX) in a case of angle-supported lens implantation. Int Ophthalmol. 2014;34(3):661–665. doi:https://doi.org/10.1007/s10792-013-9841-4.
   PubMed Web of Science ®Google Scholar
• Uwaydat SH, Wang H, Sallam AB. Intraoperative injection of intravitreal dexamethasone implant using a vitrectomy tracer-assisted technique. Retina. 2019;39(1):S123–S124. doi:https://doi.org/10.1097/IAE.0000000000001853.
   Google Scholar
• Kaplan EL, Meier P. Nonparametric-estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457–481. doi:https://doi.org/10.1080/01621459.1958.10501452.
   Web of Science ®Google Scholar
• Uwaydat SH, Sallam AB, Wang H, Goyal S. Retinal Indentation by a dexamethasone implant in a gas-filled eye: report of an unusual complication. JAMA Ophthalmol. 2017;135(10):1125–1127. doi:https://doi.org/10.1001/jamaophthalmol.2017.3276.
   PubMed Web of Science ®Google Scholar
• Chang-Lin JE, Burke JA, Peng Q, et al. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci. 2011;52(7):4605–4609. doi:https://doi.org/10.1167/iovs.10-6387.
   PubMed Web of Science ®Google Scholar
• Zarranz-Ventura J, Carreno E, Johnston RL, et al. Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency. Am J Ophthalmol. 2014;158(6):1136–1145 e1135. doi:https://doi.org/10.1016/j.ajo.2014.09.003.
   PubMed Web of Science ®Google Scholar
• Christensen L, Sanders R, Olson J. “Magic bullet”: eccentric macular hole as a complication from dexamethasone implant insertion. Case Rep Ophthalmol Med. 2016;2016:1706234.
   PubMed Web of Science ®Google Scholar
• Panjaphongse R, Liu W, Pongsachareonnont P, Stewart JM. Kinematic study of ozurdex injection in balanced salt solution: modeling the behavior of an injectable drug delivery device in vitrectomized eyes. J Ocul Pharmacol Ther. 2015;31(3):174–178. doi:https://doi.org/10.1089/jop.2014.0134.
   PubMed Web of Science ®Google Scholar
• Bansal L, Gupta A, Gupta V, et al. Safety and outcome of microincision vitreous surgery in uveitis. Ocul Immunol Inflamm. 2017;25(6):775–784. doi:https://doi.org/10.3109/09273948.2016.1165259.
   PubMed Web of Science ®Google Scholar